Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
BMC Gastroenterol. 2022 May 15;22(1):247. doi: 10.1186/s12876-022-02319-5.
Perforation and obstruction in colorectal cancer are poor prognostic factors. We aimed to evaluate the oncological outcomes of patients with colon cancer presenting with perforation or obstruction.
A total of 260 patients underwent surgery for colon cancer between January 2015 and December 2017. Among them, 54 patients who underwent emergency surgery for perforated (n = 32) or obstructive (n = 22) colon cancer were included.
The perforation (PG, n = 32) and obstruction groups (OG, n = 22) did not differ significantly in age (p = 0.486), sex (p = 0.821), tumor stage (p = 0.221), tumor location (p = 0.895), histologic grade (p = 0.173), or 3-year overall survival rate (55.6% vs. 50.0%, p = 0.784). However, the PG had a higher postoperative complication rate (44% vs. 17%, p = 0.025), longer intensive care unit stay (4.8 days vs. 0.8 days, p = 0.047), and lower 3-year recurrence-free survival (42.4% vs. 78.8%, p = 0.025) than the OG. In the multivariate analysis, perforation was significantly increased risk of recurrence (hazard ratio = 3.67, 95% confidence interval: 1.049-12.839, p = 0.042).
Patients with colon cancer initially presenting with perforation had poorer recurrence-free survival, higher postoperative complication rates, and longer ICU stays than those who had obstruction.
结直肠癌穿孔和梗阻是预后不良的因素。我们旨在评估穿孔或梗阻的结肠癌患者的肿瘤学结局。
2015 年 1 月至 2017 年 12 月期间,共有 260 例患者接受结肠癌手术。其中,54 例行穿孔(n = 32)或梗阻(n = 22)的结肠癌急症手术患者纳入研究。
穿孔组(PG,n = 32)和梗阻组(OG,n = 22)在年龄(p = 0.486)、性别(p = 0.821)、肿瘤分期(p = 0.221)、肿瘤部位(p = 0.895)、组织学分级(p = 0.173)或 3 年总生存率(55.6% vs. 50.0%,p = 0.784)方面差异无统计学意义。然而,PG 的术后并发症发生率(44% vs. 17%,p = 0.025)、重症监护病房停留时间(4.8 天 vs. 0.8 天,p = 0.047)和 3 年无复发生存率(42.4% vs. 78.8%,p = 0.025)均低于 OG。多变量分析显示,穿孔是复发的显著危险因素(危险比 = 3.67,95%置信区间:1.049-12.839,p = 0.042)。
与梗阻相比,穿孔的结肠癌患者无复发生存率较差,术后并发症发生率较高,重症监护病房停留时间较长。